Embecta Corp. revenue for the last year amounted to 1.12 B USD, the most of which — 1.12 B USD — came from its highest performing source at the moment, Diabetes Care, the year earlier bringing 1.13 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Embecta Corp. 601.40 M USD, and the year before that — 600.30 M USD.